Across TCGA pan-cancer cohorts, GOLGA2P7 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated GOLGA2P7 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher GOLGA2P7 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated GOLGA2P7 expression acts as an unfavorable survival marker, although some lineages such as MESO and LGG show a favorable association.

LIHC, KICH, and MESO are the cancer types where GOLGA2P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Median	All	0.597	0.761	<.001	73	view →
KICH	DFS	Tertile	III,IV	0.171	0.890	.002	69	view →
MESO	OS	Median	All	0.688	0.421	<.001	69	view →
KIRP	OS	Median	III,IV	0.136	0.647	.002	49	view →
LGG	DFS	Median	All	0.794	0.679	<.001	38	view →
LUAD	OS	Median	III,IV	0.560	0.749	.005	28	view →
ACC	DFS	Tertile	All	0.173	0.510	.006	25	view →
HNSC	OS	Quartile	II,III,IV	0.231	0.644	.002	21	view →
KIRC	DFS	Median	IV	0.476	0.757	.013	20	view →
DLBC	DFS	Median	II,III,IV	0.572	0.947	.005	17	view →
STAD	OS	Tertile	III,IV	0.698	0.290	.008	13	view →
PCPG	DFS	Median	All	0.647	0.904	.022	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

Exploration

Same gene, other analysis: GOLGA2P7 tumor-vs-normal RNA expression · all GOLGA2P7 data types